date:2019-01-02 Views:8232 times
查看研报附件:信达国际-康臣药业1681:2018年上半年收入实现稳定增长,推荐买入评级,目标价9.6港元。
Prev:China / Hong Kong Company Guide Consun Pharmaceutical Group
Next:None
400-930-1681
service@chinaconsun.com
71 Dongpeng Avenue, Huangpu District, Guangzhou
Friendship Link: State Food and Drug Administration Inner Mongolia Food and Drug Administration Guangdong Food and Drug Administration Guangxi Food and Drug Administration
粤ICP备15001491号Design: uweb